Parametric Portfolio Associates’s Neos Therapeutics, Inc NEOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-55,850
Closed -$146K 4023
2019
Q1
$146K Buy
55,850
+29,449
+112% +$69.1K ﹤0.01% 3768
2018
Q4
$44K Buy
26,401
+14,999
+132% +$42.1K ﹤0.01% 3859
2018
Q3
$55K Sell
11,402
-88,588
-89% -$502K ﹤0.01% 3904
2018
Q2
$625K Buy
99,990
+15,200
+18% +$113K ﹤0.01% 3259
2018
Q1
$704K Buy
84,790
+64,230
+312% +$613K ﹤0.01% 3186
2017
Q4
$210K Buy
20,560
+9,074
+79% +$87.1K ﹤0.01% 3733
2017
Q3
$105K Buy
+11,486
New +$87.3K ﹤0.01% 3948

Other funds holding NEOS

Parametric Portfolio Associates's NEOS Position: Q2 2019 in Review

Parametric Portfolio Associates sold out of Neos Therapeutics, Inc (NEOS) in Q2 2019, closing a stake of 55,850 shares — an estimated $146K sold.

Parametric Portfolio Associates first reported a position in NEOS in Q3 2017 and held it in 7 quarters. The position peaked at $704K in Q1 2018. 58 funds tracked by Wall St. Rank hold NEOS as of Q2 2019.

  • Parametric Portfolio Associates reported no remaining Neos Therapeutics, Inc position as of Q2 2019 after selling out during the quarter.
  • Parametric Portfolio Associates sold 55,850 Neos Therapeutics, Inc shares in Q2 2019, an estimated $146K.
  • Parametric Portfolio Associates first reported a position in Neos Therapeutics, Inc in Q3 2017 and held it in 7 quarters.
  • Parametric Portfolio Associates's Neos Therapeutics, Inc position peaked at $704K in Q1 2018.
  • 58 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2019.

Based on Parametric Portfolio Associates's 13F filing for Q2 2019, filed 13 Aug 2019.